Caricamento...
Combination Therapy Against Indian Visceral Leishmaniasis with Liposomal Amphotericin B (Fungisome(TM)) and Short-Course Miltefosine in Comparison to Miltefosine Monotherapy
Visceral leishmaniasis (VL) is endemic in Asia, East and North Africa, South America, and Southern Europe, and is a major public health problem in the Indian subcontinent. Miltefosine received approval in 2002 to treat VL in India, and the Indian National Vector Borne Disease Control Programme later...
Salvato in:
| Pubblicato in: | Am J Trop Med Hyg |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The American Society of Tropical Medicine and Hygiene
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356435/ https://ncbi.nlm.nih.gov/pubmed/32394874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.19-0931 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|